PolyPid Ltd. (PYPD) Form 6-K — Jun 10, 2026
PolyPid Ltd. (PYPD) filed a proxy statement for its Annual and Extraordinary General Meeting of Shareholders scheduled for July 15, 2026. The filing outlines five proposals, including the re-election of the independent auditor and the re-election of all eight members of the Board of Directors. Shareholders will vote on approving an amendment to the terms of non-executive directors' annual options, setting the exercise price at $4.46 per share based on the 30-day average prior to the board meeting.
Key figures
- Ceo option grant shares
- 149000
- Chairman annual fee usd
- 75000
- Ceo option exercise price usd
- 4.46
- Non exec director option count
- 9132
- Israeli director annual fee nis
- 37000
- Israeli director annual fee usd
- 13100
- Non exec director option value usd
- 40000
- Non israeli director annual fee usd
- 20000
- Non exec director option exercise price usd
- 4.46
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.